LAB Q4 2017 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena

LABStandard BioTools Inc.

$370M

Q4 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$28M+10.6% YoY

Gross Profit

$14M51.5% margin

Operating Income

-$9M-31.5% margin

Net Income

-$10M-37.7% margin

EPS (Diluted)

$-0.27

QoQ Revenue Growth

+12.1%

Cash Flow

Operating Cash Flow

$661,000

Free Cash Flow

$433,000

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$287M

Total Liabilities

$256M

Stockholders' Equity

$31M

Cash & Equivalents

$58M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$28M	$25M	+10.6%
Gross Profit	$14M	$14M	+3.2%
Operating Income	-$9M	-$18M	+50.6%
Net Income	-$10M	-$18M	+40.9%

Geographic Segments

CHINA

$3M100%